[HIV and glycosylation].
Nakata
M
M
Department of Applied Chemistry, Tokai University, Kanagawa, Japan.
Mizuochi
T
T
D000818:Animals; D018943:Anthracyclines; D019380:Anti-HIV Agents / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D015704:CD4 Antigens / Q000378:metabolism; D006678:HIV / Q000472:pathogenicity; D015699:HIV Envelope Protein gp120 / Q000737:chemistry / Q000378:metabolism* / Q000502:physiology; D015658:HIV Infections / Q000517:prevention & control; D006801:Humans; D037102:Lectins / Q000378:metabolism / Q000502:physiology; D008358:Mannose / Q000378:metabolism / Q000502:physiology; D011485:Protein Binding; D000095643:Pradimicins and Benanomicins
D018943:Anthracyclines; D019380:Anti-HIV Agents; D000903:Antibiotics, Antineoplastic; D000935:Antifungal Agents; D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D037102:Lectins; D008358:Mannose; C058036:pradimicin A; D000095643:Pradimicins and Benanomicins; C067714:N,N-dimethylpradimicin FA-2